Magnetic Resonance Imaging (MRI)

MRI creates images from the magnetic resonance created in hydrogen atoms when they are polarized and an electromagnetic pulse is used to knock them off axis. This section includes MR analysis software, MRI scanners, gadolinium contrast agents and related magnetic resonance imaging accessories.

Yale New Haven Children's Hospital (YNHCH) opened its state-of-the-art neonatal intensive care unit (NICU) in 2018, demonstrating the hospital’s continued commitment to provide the best in advanced care for premature babies and infants with medical complications.
News | Magnetic Resonance Imaging (MRI)
Yale New Haven Children’s Hospital Installs Groundbreaking, Patient-Focused, MRI System

December 2, 2020 — Yale New Haven Children's Hospital (YNHCH) opened its state-of-the-art neonatal intensive care unit ...

Time December 02, 2020
arrow
By eliminating the need to move neonates from the NICU to the radiology department, Aspect Imaging’s Embrace enables a safer way to perform the MRI procedure
News | Magnetic Resonance Imaging (MRI)
Aspect Imaging Lauded by Frost & Sullivan for Its Revolutionary Embrace Neonatal MRI System

December 1, 2020 — Based on its recent analysis of the global neonatal intensive care unit magnetic resonance imaging ...

Time December 01, 2020
arrow
Resoundant Inc., announced hat it has entered into a strategic partnership with United Imaging Healthcare to begin offering advanced magnetic resonance elastography (MRE) on leading United Imaging MRI systems.
News | Magnetic Resonance Imaging (MRI)
Resoundant Announces Partnership with United Imaging

November 30, 2020 — Resoundant Inc., announced that it has entered into a strategic partnership with United Imaging ...

Time November 30, 2020
arrow
Showcasing Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology on wider range of clinical applications, more modalities and systems
News | Artificial Intelligence
Canon Expands Its AI-Based Image Reconstruction Technology

November 30, 2020 — Canon Medical is bringing the power of accessible artificial intelligence (AI) for improved image ...

Time November 30, 2020
arrow
Chest CT images in a 34-year-old man with fever for 4 days. Positive result of reverse-transcription polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 using a swab sample was obtained on February 8, 2020. Dates of examination are shown on images. A, Chest CT scan with magnification of lesions in coronal and sagittal planes shows a nodule with reversed halo sign in left lower lobe (box) at the early stage of the pneumonia. B, Chest CT scans in different axial planes and coro
News | Coronavirus (COVID-19)
COVID-19 Research Receives RSNA Margulis Award

November 29, 2020 — The Radiological Society of North America (RSNA) presented its ninth Alexander R. Margulis Award for ...

Time November 29, 2020
arrow
GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent, Clariscan (gadoterate meglumine), in pre-filled syringes. #RSNA20
News | Contrast Media
GE Healthcare Announces U.S. FDA approval of macrocyclic MRI Contrast Agent Clariscan in Pre-Filled Syringes

November 26, 2020 — GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent ...

Time November 26, 2020
arrow
ASG well positioned for growth as healthcare marketplace continues to evolve 
News | Radiology Imaging
Alpha Source Group Names New CEO, Expands Customized Service Solutions to Focus on OEM Partnerships

November 24, 2020 — Alpha Source Group (ASG), a comprehensive next-generation services partner, has named Allan Klotsche ...

Time November 24, 2020
arrow
1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well
News | Coronavirus (COVID-19)
Early Details of Brain Damage in COVID-19 Patients

November 19, 2020 — One of the first spectroscopic imaging-based studies of neurological injury in COVID-19 patients has ...

Time November 19, 2020
arrow
SyntheticMR, an innovative software solutions company for magnetic resonance imaging (MRI) announced today the company filed a 510(k) submission for its musculoskeletal solutions package, SyMRI MSK.
News | Magnetic Resonance Imaging (MRI)
SyntheticMR Announces Submission of 510(k) to FDA for Quantitative MSK MRI Package

November 17, 2020 — SyntheticMR, an innovative software solutions company for magnetic resonance imaging (MRI) announced ...

Time November 17, 2020
arrow
GE Healthcare announced U.S. FDA 510(k) clearance of SIGNA 7.0T magnetic resonance imaging (MRI) scanner. With a magnet approximately five times more powerful than most clinical systems, SIGNA 7.0T can image anatomy, function, metabolism and microvasculature in the brain and joints with incredible resolution and detail.
News | Magnetic Resonance Imaging (MRI)
GE's SIGNA 7.0T Receives FDA Clearance

November 12, 2020 — GE Healthcare announced U.S. FDA 510(k) clearance of its SIGNA 7.0T magnetic resonance imaging (MRI) ...

Time November 12, 2020
arrow
Honoring essential healthcareprofessionals, Nov. 8-14
News | Radiology Imaging
Radiologic Technologists Play Crucial Role in COVID-19 Diagnosis

November 9, 2020 — As COVID-19 continues to spread in communities throughout the country, Americans rely on radiologic ...

Time November 09, 2020
arrow
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 
Feature | Magnetic Resonance Imaging (MRI)
Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events

October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very ...

Time October 29, 2020
arrow
Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.
Feature | Magnetic Resonance Imaging (MRI)
MRI Can Be Safely Performed in Patients With Pacemakers and ICDs

October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR ...

Time October 27, 2020
arrow
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI)
ASTRO 2020 to Feature Latest MRIdian Clinical Experience Highlighting Outcomes in Tough to Treat Cancer

October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will be ...

Time October 26, 2020
arrow
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large
News | Magnetic Resonance Imaging (MRI)
Global MRI Data Offers Hope for Improving Treatment of Brain Injuries

October 23, 2020 — Traumatic brain injury is a major cause of disability and can have major consequences for patients ...

Time October 23, 2020
arrow
The fMRI hyperscanning environment.
News | Clinical Trials
Dual Brain Imaging Provides Insight Into Neural Basis of Patient-clinician Relationship

October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is ...

Time October 22, 2020
arrow
The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer
Quantib Receives FDA Clearance for First-to-Market Prostate Solution

October 21, 2020 — Quantib, a market leader in artificial intelligence solutions for radiology, today announced that it ...

Time October 21, 2020
arrow
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)
News | Magnetic Resonance Imaging (MRI)
Body MRI Reinterpretations Plagued by Discrepancies and Errors

October 21, 2020 — According to an article in ARRS' American Journal of Roentgenology (AJR), secondary interpretations ...

Time October 21, 2020
arrow
Flowchart of patient inclusion and exclusion.
News | Coronavirus (COVID-19)
Multi-Institutional Study Looks at Brain MRI Findings in COVID-19

October 20, 2020 — A new multi-institutional study published in the journal Radiology identifies patterns in abnormal ...

Time October 20, 2020
arrow
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence
Ezra Receives FDA Clearance For Prostate Cancer Artificial Intelligence

October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI) ...

Time October 20, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now